Thursday, March 14, 2013

Jive Software Inc (NASDAQ: JIVE)

Jive Software, Inc. provides a social business software platform to businesses, government agencies, and other enterprises. Its Jive Engage Platform enables collaboration across two principal communities and employees within the enterprise, and customers and partners outside the enterprise. The company's Jive Engage Platform is used as a communications tool and collaborative workspace that supports and enhances knowledge sharing, facilitates communication within and across organizational boundaries, and enables individuals to work together to achieve common business goals. Its platform allows customers and partners of the enterprise to connect socially with one another, as well as with the enterprise, in a structured online community that enables users to ask questions, post answers, and communicate about a product or particular issue. In addition, it provides Jive What Matters, a user interface to track, consume, manage, and filter critical business information, communications, and actions; Jive Apps Market, a secure market of business applications that are integrated to and accessed from within the Jive Engage Platform; and professional, support, and training services.
To analyze Jive's stock for potential trading opportunities, please take a look at the 1-year chart of JIVE (Jive Software, Inc.) below with my added notations:
1-year chart of JIVE (Jive Software, Inc.) The main price level to watch on JIVE is $16 (blue). Not only was the $16 resistance readily apparent over the (7) months and back in March, but that price also acted as support just last week. So, the $16 level is key to this stock. Assuming the stock moves higher, the increments of $2 (red) have also acted as common price levels for the stock.
The Tale of the Tape: JIVE's key level to watch is $16. A long position could be entered at the $16 support with a stop placed below that level, or a short play could be made on a break below $16 if that should happen.
Please bookmark us

No comments:

Post a Comment